Lung Cancer Screening Market: By Cancer Type, and Small Cell Lung Cancer), By Diagnosis Type, By End-Users and Geography  

Lung Cancer Screening Market Size, Share, Growth, Trends, and Global Industry Analysis: By Cancer Type (Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer), By Diagnosis Type (Low Dose Spiral CT scan, And Chest X-Ray), By End-Users (Hospital & Clinics and Diagnostic Centers) and Region  

Lung Cancer Screening Market size was valued at US$ 2,862.1 million in 2023 and is poised to grow at a significant CAGR of 6.5% from 2024-2030. A type of disease that occurs in the lungs is known as lung cancer. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the 2 main types of lung cancer and are treated differently. The non-small cell lung cancer segment is anticipated to grow at a significant CAGR over the forecast years owing to non-small cell lung cancer being the most common type of cancer accounting for approximately 85% of all lung cancers.

However, non-small cell Lung cancer metastasizes to another organ slower in compression to SCLC, and microscopically, SCLC is composed of much smaller cells. if untreated, SCLC can be fatal in a few weeks, in contrast to most cases of NSCLC. Moreover, as per the research, non-small cell lung cancer accounts for 85% of all lung cancer cases in the United States after the initial diagnosis. The prevalence of lung cancer cases worldwide, greater emphasis on technological developments in the production of medical devices, and rising spending on the expansion of healthcare infrastructure, particularly in developing economies, are the main drivers of the market.

Lung Cancer Screening Market Key Developments

  • In November 2023, Thirona, Incepto, and Aidence jointly introduced a clinical solution to help lung cancer screening spread throughout Europe. This cooperative initiative represents a calculated step to improve screening capacities and help identify and treat lung cancer more effectively throughout the continent.
  • In November 2023, Thynk Health and Infervision established a strategic partnership that will use the most cutting-edge technology available to fight lung cancer. Through this partnership, Thynk Health is positioned as a major participant in pulmonary nodule management and cutting-edge healthcare solutions, in addition to facilitating enhanced lung cancer detection.

Lung Cancer Screening Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.5%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Lung Cancer Screening Market Dynamics

The lung cancer screening market is anticipated to grow in the forecasting period owing to surge in the incidence of the type of cancer due to increase smoking population, technology advancement in screening, and increasing in government support of early detection of cases. Moreover, other player is focusing on strategy and collaboration are also likely to boost the market growth in the near future. For instance, In September 2021Genentech and Roche are actively exploring the development of biomarker to test lung cancer and detection.

Lung Cancer Screening Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 2,862.1 million

Market CAGR

6.5%

By Cancer Type

  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer

By Diagnosis Type

  • Low Dose Spiral CT scan
  • Chest X-Ray

By End User

  • Hospital & Clinics
  • Diagnostic Centers

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Key Features of the Report

  • The lung cancer screening market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

The global lung cancer screening market size was valued at US$ 2,862.1 million in 2023 and is projected to grow at a significant CAGR of 6.5% from 2024-2030

PenRad Technologies Inc., Koninklijke Philips N.V, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmbH

Asia Pacific is the fastest-growing region for lung cancer screening market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Lung Cancer Screening Market Introduction 
2.1.Global Lung Cancer Screening Market  - Taxonomy
2.2.Global Lung Cancer Screening Market  - Definitions
2.2.1. By Cancer Type
2.2.2. By Diagnosis Type
2.2.3. By End User
2.2.4. By Region
3.Global Lung Cancer Screening Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Lung Cancer Screening Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Lung Cancer Screening Market  By Cancer Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Non-Small Cell Lung Cancer (NSCLC)
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Small Cell Lung Cancer
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Lung Cancer Screening Market  By Diagnosis Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Low Dose Spiral CT scan
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Chest X-Ray
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Lung Cancer Screening Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital & Clinics
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diagnostic Centers
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Lung Cancer Screening Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Lung Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Non-Small Cell Lung Cancer (NSCLC)
9.1.2.Small Cell Lung Cancer
9.2.  Diagnosis Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Low Dose Spiral CT scan
9.2.2.Chest X-Ray
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital & Clinics
9.3.2.Diagnostic Centers
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Lung Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Cancer Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Non-Small Cell Lung Cancer (NSCLC)
10.1.2.Small Cell Lung Cancer
10.2.  Diagnosis Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Low Dose Spiral CT scan
10.2.2.Chest X-Ray
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital & Clinics
10.3.2.Diagnostic Centers
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Lung Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Cancer Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Non-Small Cell Lung Cancer (NSCLC)
11.1.2.Small Cell Lung Cancer
11.2.  Diagnosis Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Low Dose Spiral CT scan
11.2.2.Chest X-Ray
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital & Clinics
11.3.2.Diagnostic Centers
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Lung Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Cancer Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Non-Small Cell Lung Cancer (NSCLC)
12.1.2.Small Cell Lung Cancer
12.2.  Diagnosis Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Low Dose Spiral CT scan
12.2.2.Chest X-Ray
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital & Clinics
12.3.2.Diagnostic Centers
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Lung Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Cancer Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Non-Small Cell Lung Cancer (NSCLC)
13.1.2.Small Cell Lung Cancer
13.2.  Diagnosis Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Low Dose Spiral CT scan
13.2.2.Chest X-Ray
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital & Clinics
13.3.2.Diagnostic Centers
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.PenRad Technologies Inc.
14.2.2.Koninklijke Philips N.V
14.2.3.Volpara Health Limited
14.2.4.Thynk Health
14.2.5.Nuance Communications, Inc.
14.2.6.Siemens Healthcare GmbH
14.2.7.MyCareWare, Inc.
14.2.8.MagView
14.2.9.MeVis Medical Solutions AG
14.2.10.Canon Medical Informatics, Inc.
14.2.11.General Electric Company
14.2.12.Epic Systems Corporation
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • PenRad Technologies Inc.
  • Koninklijke Philips N.V
  • Volpara Health Limited
  • Thynk Health
  • Nuance Communications, Inc.
  • Siemens Healthcare GmbH
  • MyCareWare, Inc.
  • MagView
  • MeVis Medical Solutions AG
  • Canon Medical Informatics, Inc.
  • General Electric Company
  • Epic Systems Corporation
  • Lungview
  • Eon
  • Medtronic
  • HealthMyne
  • Oncocyte Corporation
  • Genesystem
  • FUJIFILM Holdings Corporation
  • Median Technologies
  • AstraZeneca

Related Industry Reports